BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 31430188)

  • 1. Proton therapy for locally advanced non-small cell lung cancer.
    Gjyshi O; Liao Z
    Br J Radiol; 2020 Mar; 93(1107):20190378. PubMed ID: 31430188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Consensus Statement on Proton Therapy in Early-Stage and Locally Advanced Non-Small Cell Lung Cancer.
    Chang JY; Jabbour SK; De Ruysscher D; Schild SE; Simone CB; Rengan R; Feigenberg S; Khan AJ; Choi NC; Bradley JD; Zhu XR; Lomax AJ; Hoppe BS;
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):505-516. PubMed ID: 27084663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton arc reduces range uncertainty effects and improves conformality compared with photon volumetric modulated arc therapy in stereotactic body radiation therapy for non-small cell lung cancer.
    Seco J; Gu G; Marcelos T; Kooy H; Willers H
    Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):188-94. PubMed ID: 23920395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proton Therapy in Non-small Cell Lung Cancer.
    Mesko S; Gomez D
    Curr Treat Options Oncol; 2018 Nov; 19(12):76. PubMed ID: 30483900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photons or protons for reirradiation in (non-)small cell lung cancer: Results of the multicentric ROCOCO
    Troost EGC; Wink KCJ; Roelofs E; Simone CB; Makocki S; Löck S; van Kollenburg P; Dechambre D; Minken AWH; van der Stoep J; Avery S; Jansen N; Solberg T; Bussink J; de Ruysscher D
    Br J Radiol; 2020 Mar; 93(1107):20190879. PubMed ID: 31804145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Normal Tissue Injury Induced by Photon and Proton Therapies: Gaps and Opportunities.
    Prasanna PG; Rawojc K; Guha C; Buchsbaum JC; Miszczyk JU; Coleman CN
    Int J Radiat Oncol Biol Phys; 2021 Aug; 110(5):1325-1340. PubMed ID: 33640423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significant reduction of normal tissue dose by proton radiotherapy compared with three-dimensional conformal or intensity-modulated radiation therapy in Stage I or Stage III non-small-cell lung cancer.
    Chang JY; Zhang X; Wang X; Kang Y; Riley B; Bilton S; Mohan R; Komaki R; Cox JD
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1087-96. PubMed ID: 16682145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intensity-modulated radiotherapy for locally advanced non-small-cell lung cancer: a dose-escalation planning study.
    Lievens Y; Nulens A; Gaber MA; Defraene G; De Wever W; Stroobants S; Van den Heuvel F;
    Int J Radiat Oncol Biol Phys; 2011 May; 80(1):306-13. PubMed ID: 20888706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton versus photon-based radiation therapy for prostate cancer: emerging evidence and considerations in the era of value-based cancer care.
    Kamran SC; Light JO; Efstathiou JA
    Prostate Cancer Prostatic Dis; 2019 Dec; 22(4):509-521. PubMed ID: 30967625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intensity modulated radiation therapy and proton radiotherapy for non-small cell lung cancer.
    Chang JY; Liu HH; Komaki R
    Curr Oncol Rep; 2005 Jul; 7(4):255-9. PubMed ID: 15946583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Quest for Evidence for Proton Therapy: Model-Based Approach and Precision Medicine.
    Widder J; van der Schaaf A; Lambin P; Marijnen CAM; Pignol JP; Rasch CR; Slotman BJ; Verheij M; Langendijk JA
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):30-36. PubMed ID: 26684410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spatial Dose Patterns Associated With Radiation Pneumonitis in a Randomized Trial Comparing Intensity-Modulated Photon Therapy With Passive Scattering Proton Therapy for Locally Advanced Non-Small Cell Lung Cancer.
    Palma G; Monti S; Xu T; Scifoni E; Yang P; Hahn SM; Durante M; Mohan R; Liao Z; Cella L
    Int J Radiat Oncol Biol Phys; 2019 Aug; 104(5):1124-1132. PubMed ID: 30822531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Photons, protons or carbon ions for stage I non-small cell lung cancer - Results of the multicentric ROCOCO in silico study.
    Wink KCJ; Roelofs E; Simone CB; Dechambre D; Santiago A; van der Stoep J; Dries W; Smits J; Avery S; Ammazzalorso F; Jansen N; Jelen U; Solberg T; de Ruysscher D; Troost EGC
    Radiother Oncol; 2018 Jul; 128(1):139-146. PubMed ID: 29545019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sparing Cardiac Substructures With Optimized Volumetric Modulated Arc Therapy and Intensity Modulated Proton Therapy in Thoracic Radiation for Locally Advanced Non-small Cell Lung Cancer.
    Ferris MJ; Martin KS; Switchenko JM; Kayode OA; Wolf J; Dang Q; Press RH; Curran WJ; Higgins KA
    Pract Radiat Oncol; 2019; 9(5):e473-e481. PubMed ID: 31077884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of a multicentric in silico clinical trial (ROCOCO): comparing radiotherapy with photons and protons for non-small cell lung cancer.
    Roelofs E; Engelsman M; Rasch C; Persoon L; Qamhiyeh S; de Ruysscher D; Verhaegen F; Pijls-Johannesma M; Lambin P;
    J Thorac Oncol; 2012 Jan; 7(1):165-76. PubMed ID: 22071782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dosimetric comparison of advanced radiotherapy approaches using photon techniques and particle therapy in the postoperative management of thymoma.
    Haefner MF; Verma V; Bougatf N; Mielke T; Tonndorf-Martini E; König L; Rwigema JM; Simone CB; Uhlmann L; Eichhorn F; Winter H; Grosch H; Haberer T; Herfarth K; Debus J; Rieken S
    Acta Oncol; 2018 Dec; 57(12):1713-1720. PubMed ID: 30264630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IMRT and 3D conformal radiotherapy with or without elective nodal irradiation in locally advanced NSCLC: A direct comparison of PET-based treatment planning.
    Fleckenstein J; Kremp K; Kremp S; Palm J; Rübe C
    Strahlenther Onkol; 2016 Feb; 192(2):75-82. PubMed ID: 26438071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer Trials Ireland (ICORG) 06-34: A multi-centre clinical trial using three-dimensional conformal radiation therapy to reduce the toxicity of palliative radiation for lung cancer.
    McDermott RL; Armstrong JG; Thirion P; Dunne M; Finn M; Small C; Byrne M; O'Shea C; O'Sullivan L; Shannon A; Kelly E; Hacking DJ
    Radiother Oncol; 2018 May; 127(2):253-258. PubMed ID: 29548561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limited Impact of Setup and Range Uncertainties, Breathing Motion, and Interplay Effects in Robustly Optimized Intensity Modulated Proton Therapy for Stage III Non-small Cell Lung Cancer.
    Inoue T; Widder J; van Dijk LV; Takegawa H; Koizumi M; Takashina M; Usui K; Kurokawa C; Sugimoto S; Saito AI; Sasai K; Van't Veld AA; Langendijk JA; Korevaar EW
    Int J Radiat Oncol Biol Phys; 2016 Nov; 96(3):661-9. PubMed ID: 27681763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential benefits of scanned intensity-modulated proton therapy versus advanced photon therapy with regard to sparing of the salivary glands in oropharyngeal cancer.
    van de Water TA; Lomax AJ; Bijl HP; de Jong ME; Schilstra C; Hug EB; Langendijk JA
    Int J Radiat Oncol Biol Phys; 2011 Mar; 79(4):1216-24. PubMed ID: 20732761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.